Celtic Pharma Holdings

• Home
• Go back
• About CPH Advisors
• Funds Under Management
• Introduction
• Strategy
• Benefits to Investee Companies

• News

Celtic Pharma Holdings and PolyTherics announce investment into novel biopharmaceutical programme

Guernsey and London, 26th January 2010 – Celtic Pharma Holdings Advisors LLP (“CPHA”), the advisor to Celtic Pharma Holdings II LP (“CP2”), together w...

Celtic Pharma Holdings commits significant funding to Cantab Biopharmaceuticals to drive the development of improved biological medicines – ‘biosuperiors’; Jim Mills appointed as Cantab CEO

Guernsey and London, 25th January 2010 – Celtic Pharma Holdings Advisors LLP (“CPHA”), today announces it has made significant funding available to Cantab Biophar...

Celtic Pharma Holdings Appoints Dr. Andy Richards to its Advisory Board

Guernsey and London, 2nd October 2009 – Celtic Pharma Holdings Advisors LLP (“CPHA”), the advisor to the second Celtic Pharma fund, Celtic Pharma Holdings II LP (...